We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.24B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+7.45%
1 Year Est. Return
+28.12%
3 Year Est. Return
+86.66%
5 Year Est. Return
+111.98%
10 Year Est. Return
+372.59%
AUM
$945M
AUM Growth
+$66.7M
Cap. Flow
+$6.04M
Cap. Flow %
0.64%
Top 10 Hldgs %
68.38%
Holding
92
New
2
Increased
34
Reduced
45
Closed
4

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$18.2M
2
CL icon
Colgate-Palmolive
CL
+$2.85M
3
K
Kellanova
K
+$2.22M
4
BAX icon
Baxter International
BAX
+$1.48M
5
AMGN icon
Amgen
AMGN
+$1.37M

Top Sells

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$4.29M
2
ORCL icon
Oracle
ORCL
+$2.51M
3
PEP icon
PepsiCo
PEP
+$2.27M
4
SLB icon
SLB Ltd
SLB
+$2.14M
5
CLX icon
Clorox
CLX
+$1.92M

Sector Composition

Rank Sector Weight
1 Consumer Staples 46.52%
2 Healthcare 18.92%
3 Energy 9.17%
4 Industrials 5.89%
5 Financials 4.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
K
51
DELISTED
Kellanova
K
$2.27M 0.24%
+36,902
New +$2.22M
PX
52
DELISTED
Praxair Inc
PX
$2.17M 0.23%
16,780
-1,000
-6% -$127K
ADBE icon
53
Adobe
ADBE
$94.5B
$2.17M 0.23%
29,800
+6,600
+28% +$463K
LLY icon
54
Eli Lilly
LLY
$1.07T
$2.16M 0.23%
31,300
-1,900
-6% -$128K
BP icon
55
BP
BP
$109B
$2.14M 0.23%
67,564
-3,287
-5% -$110K
DEO icon
56
Diageo
DEO
$47.3B
$2.12M 0.22%
18,606
-3,250
-15% -$378K
ORCL icon
57
Oracle
ORCL
$345B
$2.08M 0.22%
46,330
-61,570
-57% -$2.51M
MO icon
58
Altria Group
MO
$122B
$2M 0.21%
40,655
-21,925
-35% -$1.07M
CSX icon
59
CSX Corp
CSX
$96B
$1.7M 0.18%
140,577
-51,900
-27% -$608K
DD
60
DELISTED
Du Pont De Nemours E I
DD
$1.66M 0.18%
23,656
-2,843
-11% -$190K
FITB
61
Fifth Third Bancorp
FITB
$51.7B
$1.65M 0.17%
80,840
– –
XLNX
62
DELISTED
Xilinx Inc
XLNX
$1.56M 0.17%
36,150
+1,800
+5% +$77.9K
DVN icon
63
Devon Energy
DVN
$49.8B
$1.56M 0.16%
25,460
-2,480
-9% -$150K
GAP
64
The Gap Inc
GAP
$7.07B
$1.54M 0.16%
36,505
+24,875
+214% +$975K
CI icon
65
Cigna
CI
$77B
$1.52M 0.16%
14,740
-960
-6% -$94.6K
FISV
66
Fiserv Inc
FISV
$27.9B
$1.46M 0.15%
41,080
+17,080
+71% +$585K
NSC icon
67
Norfolk Southern
NSC
$77.1B
$1.45M 0.15%
13,207
-3,100
-19% -$340K
STJ
68
DELISTED
St Jude Medical
STJ
$1.44M 0.15%
22,100
+6,500
+42% +$419K
CB icon
69
Chubb
CB
$139B
$1.41M 0.15%
12,300
-1,600
-12% -$177K
MSS
70
DELISTED
MILESTONE SCIENTIFIC INC (NEW)
MSS
$1.31M 0.14%
33,780
+1,000
+3% +$38.8K
ALL icon
71
Allstate
ALL
$67.3B
$1.2M 0.13%
17,026
-400
-2% -$26.3K
MRSH
72
Marsh
MRSH
$87.5B
$1.14M 0.12%
20,000
– –
BAC icon
73
Bank of America
BAC
$436B
$1.1M 0.12%
61,350
-2,900
-5% -$49.6K
JCI icon
74
Johnson Controls International
JCI
$87.5B
$960K 0.1%
18,981
-391
-2% -$19.1K
UBS icon
75
UBS Group
UBS
$172B
$852K 0.09%
50,000
-50,000
-50% -$856K
1 2
3
4

Similar funds

WTA
Washington Trust Advisors Wellesley, Massachusetts $1.24B AUM 22.58% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
GX
Greylock XIV Menlo Park, California $1.24B AUM
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Cullinan Associates's Q4 2014 Portfolio in Review

As of Q4 2014, Cullinan Associates held 92 positions worth $945M, up 7.6% from $878M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Cullinan Associates's Q4 2014 filing shows 2 new, 34 increased, 45 reduced and 4 closed positions. Its largest new stake was Kellanova: 36,902 shares worth $2.27M. The largest sale was Coca-Cola, an estimated $4.29M.

By sector, the portfolio is most concentrated in Consumer Staples at 47% of assets, up from 46% a quarter earlier, followed by Healthcare and Energy.

  • Cullinan Associates's largest Q4 2014 buy was Kellanova: 36,902 shares worth $2.27M.
  • Cullinan Associates added most to Bristol-Myers Squibb in Q4 2014, an estimated $18.2M increase.
  • Cullinan Associates's biggest Q4 2014 reduction was Coca-Cola, cutting an estimated $4.29M.
  • Cullinan Associates fully exited Clorox in Q4 2014, selling an estimated $1.92M.
  • Cullinan Associates's ten largest holdings make up 68% of its $945M portfolio in Q4 2014.
  • Cullinan Associates opened 2 new positions and closed 4 in Q4 2014.
  • Cullinan Associates's portfolio value rose 7.6% quarter-over-quarter to $945M.

Based on Cullinan Associates's 13F filing for Q4 2014, filed 21 Jan 2015.